Pharma Pulse 5/6/24: Are Smartphones Driving Teens to Depression? Does Pharma Know What Their Customers Really Want? & more


The latest news for pharma industry insiders.

Hey Pharma–Do You Know What Your Customers Really Want?

Running a healthcare practice is hard, filled with critical daily activities that aren’t covered in medical school. Patients need help with their insurance companies, staff needs help following up with patients—and everyone needs help navigating electronic health records. These pain points offer a prime opportunity for pharma brands to support physicians and to demonstrate true customer centricity. But is that enough?

Older Adults' Concerns Highlight Healthcare Cost and Access Challenges

The University of Michigan National Poll on Healthy Aging recently conducted the survey focusing on the concerns of adults aged 50 and above regarding various health-related issues in their communities.

Are Smartphones Driving Our Teens to Depression?

The evidence reveals a more complicated reality than the conventional wisdom would have you believe.

FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV

Gilead Sciences, Inc. announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, B/F/TAF) to treat pregnant people with HIV-1 (PWH) with suppressed viral loads.

@WebMD on Twitter/X:

In recent weeks, COVID-19 forecasters have reported on a new set of variants picked up in wastewater surveillance. Nicknamed FLiRT, they’re threatening to cause a new wave of COVID infections, which recently bottomed out after spiking in December.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs

© 2024 MJH Life Sciences

All rights reserved.